XARELTO for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 1,492 adverse event reports in the FDA FAERS database where XARELTO was used for Atrial fibrillation.
Most Reported Side Effects for XARELTO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pulmonary embolism | 276 | 7.9% | 27 | 134 |
| Deep vein thrombosis | 234 | 6.7% | 7 | 98 |
| Drug ineffective | 199 | 5.7% | 10 | 98 |
| Gastrointestinal haemorrhage | 198 | 5.7% | 38 | 148 |
| Cerebrovascular accident | 180 | 5.1% | 18 | 92 |
| Haemoglobin decreased | 166 | 4.7% | 21 | 112 |
| Fall | 124 | 3.5% | 39 | 81 |
| Anaemia | 123 | 3.5% | 9 | 88 |
| Haemorrhage | 121 | 3.5% | 28 | 67 |
| Cerebral haemorrhage | 110 | 3.1% | 50 | 80 |
| Thrombosis | 106 | 3.0% | 4 | 36 |
| Dyspnoea | 97 | 2.8% | 11 | 55 |
| Incorrect dose administered | 93 | 2.7% | 8 | 45 |
| Dizziness | 91 | 2.6% | 4 | 37 |
| Epistaxis | 90 | 2.6% | 11 | 52 |
Other Indications for XARELTO
Cerebrovascular accident prophylaxis (1,433)
Product used for unknown indication (683)
Deep vein thrombosis (506)
Embolism venous (366)
Thrombosis prophylaxis (364)
Pulmonary embolism (284)
Knee arthroplasty (77)
Thrombosis (74)
Anticoagulant therapy (39)
Hip arthroplasty (36)
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)